GENVR · Insider Trading

Gen Digital Inc. Contingent Value Rights

Every open-market purchase and sale reported by GENVR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
27
most recent
Open-Market Buys
3
code P
Sales
3
code S
Reporting Insiders
11
current holders
GENVR — Recent Form 4 Transactions (latest 2026-06-12)
FiledInsiderRole TypeSharesValue
2026-06-12 Ondrej Vlcek Director Sell −100,000 −$2.48M
2026-06-05 John C Chrystal Director Buy +3,000 +$81.17K
2026-06-03 Ondrej Vlcek Director F −128 −$3.55K
2026-05-12 Vincent Pilette CEO, Pres. & Chair A +498,896 —
2026-05-12 Bryan Seuk Ko COO, CLO and Secretary A +135,118 —
2026-05-12 Natalie Marie Derse CFO A +135,118 —
2026-05-05 Vincent Pilette CEO, Pres. & Chair MIXED +247,558 +$4.89M
2026-05-05 Bryan Seuk Ko COO, CLO and Secretary MIXED +50,025 +$990.87K
2026-05-05 Natalie Marie Derse CFO MIXED +69,795 +$1.38M
2026-03-03 Ondrej Vlcek Director F −128 −$2.89K
2026-02-19 Natalie Marie Derse CFO MIXED — −$2.75K
2026-02-19 Bryan Seuk Ko COO, CLO and Secretary A +905 +$18.25K
2026-02-19 Vincent Pilette CEO, Pres. & Chair A +795 +$16.03K
2025-12-12 Ondrej Vlcek Director Sell −113,674 −$3.08M
2025-12-03 Ondrej Vlcek Director F −128 −$3.36K
2025-11-14 John C Chrystal Director Buy +5,000 +$135.69K
2025-11-04 Ondrej Vlcek Director F −19,434 −$512.28K
2025-09-11 Sue Barsamian Director MIXED +8,822 —
2025-09-11 Pavel Baudis Director MIXED +5,810 −$88.76K
2025-09-11 Eric Brandt Director MIXED +8,822 —
2025-09-11 John C Chrystal Director A +10,518 +$49.98K
2025-09-11 Nora Denzel Director A +8,822 —
2025-09-11 Emily Heath Director A +8,822 —
2025-09-11 Sherrese M Smith Director A +10,518 +$49.98K
2025-09-11 Ondrej Vlcek Director A +10,518 +$49.98K
2025-08-15 Bryan Seuk Ko CLO & Head Corp Aff Sell −41,084 −$1.31M
2025-08-15 John C Chrystal Director Buy +10,000 +$321.00K
GENVR — Current Insider Holders
InsiderRole Shares HeldValue
Pavel Baudis Director 49,852,762 $60.82M
Ondrej Vlcek Director 4,134,724 $5.04M
Vincent Pilette CEO, Pres. & Chair 2,347,759 $2.86M
Bryan Seuk Ko COO, CLO and Secretary 772,510 $942.46K
Natalie Marie Derse CFO 661,591 $807.14K
Sue Barsamian Director 109,923 $134.11K
Eric Brandt Director 88,544 $108.02K
Sherrese M Smith Director 72,186 $88.07K
Emily Heath Director 67,202 $81.99K
Nora Denzel Director 43,682 $53.29K
John C Chrystal Director 31,419 $38.33K
GENVR Insider Trading FAQ
Who are the insiders at GENVR?
11 officers, directors and 10%+ beneficial owners currently report holdings in GENVR via SEC Form 4.
Are GENVR insiders buying or selling?
Across the 27 most recent Form 4 filings for GENVR, 3 were open-market purchases (code P) and 3 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is GENVR insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent GENVR filing is dated 2026-06-12.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the GENVR quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.